Alamar Biosciences Inc

NAS:ALMRHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$26.30+4.03%At closeAt close · Tue 20 Oct · ≈ AED 96.59 · Market cap $1.83B · Next earnings Tue 3 Nov · Extended $26.71 +1.56%

USD millions	FY2024	FY2025
Revenue	25.1	74.2
Cost of revenue	16.5	32.5
Gross profit	8.6	41.7
Research & development	39.2	37.5
Selling, general & administrative	—	35.6
Selling & marketing	—	0.0
Operating expenses	58.2	73.0
Operating income	(49.6)	(31.3)
Interest expense	2.1	0.4
Interest income	4.7	2.2
Other income / expense	—	2.2
Pre-tax income	(47.1)	(29.2)
Income tax	0.0	0.7
Net income	(47.1)	(29.8)
Discontinued operations	—	0.0
Other net income adjustments	—	0.0
EPS, basic (per share)	(0.71)	(0.45)
EPS, diluted (per share)	(0.71)	(0.45)
EBITDA	(46.4)	(24.9)
Depreciation & amortization	3.2	3.9
Weighted average shares (shares)	66,521,425	66,521,424
Weighted average diluted shares (shares)	66,521,425	66,521,424
Gross margin	34.2%	56.2%
Operating margin	−197.2%	−42.2%
Net margin	−187.2%	−40.2%